Folie 1

Previous Page

Next Page

Page Background

/

ESTRO SBRT Course 2015 - Emerging SBRT indications

6

• Rapid progression of 1/3 of the patients

Pancreatic cancer – PAP 007

Locally advanced pancreatic cancer

4 x Gem

4 x Gem& erlotinib

N=449

Progression free

CT only

N=269

54Gy Cap